Objective: To investigate consistency of lymphocyte immunophenotype between labial gland and peripheral blood in patients with primary Sjogren's syndrome (pSS).
| INTRODUC TI ON
Primary Sjögren's Syndrome (pSS) is an autoimmune disease characterized by exocrine gland hypofunction. Many studies analyzed the prevalence and characteristics of systemic involvement in pSS. 1, 2 The European League against Rheumatism (EULAR) task force on SS developed the EULAR-SS disease activity index (ESSDAI), which includes specific organ-by-organ definitions. Clinically, the ESSDAI provides a reliable picture of systemic involvement in pSS. 3, 4 The evaluation of systemic involvement in pSS in a cohort of 921 Spanish patients using the ESSDAI definitions showed that pSS is undeniably a systemic disease, with the joints, lungs, skin, and peripheral nerves being the most frequently involved organs. Cytopenias, hypocomplementaemia, and cryoglobulinaemia at diagnosis strongly correlated with higher cumulative ESSDAI scores in the clinical domains. 5 The lacrimal gland and salivary gland are involved mostly in pSS, leading to xerophthalmia or xerostomia, accompanied with hypergammaglobulinemia and increased multiple autoantibodies. 6 The gold standard for diagnosis of pSS is to confirm lymphocyte infiltration in salivary gland with histopathological examination, 7 in which lacrimal gland biopsy is the most common. However, it has been debated whether T lymphocytes or B lymphocytes are predominant in the lymphocyte infiltrate in the salivary gland and whether there is a consistency on the immunophenotype of lymphocytes of the salivary gland and blood circulation. B cells, express CD20, but plasmacytes do not express CD20. 9 The main function of CD20 is to regulate activation, proliferation, and differentiation of B cells. Therefore, CD20 has been used to locate B cells.
In this study, we analyzed infiltrating lymphocytes in the labial gland and the peripheral blood of pSS patients to confirm whether there are the deposits of immunoglobulins and complements in the labial gland and whether immune impairment in the labial gland is associated with the hypergammaglobulinemia.
| SUBJEC TS AND ME THODS

| Subjects
The prospective study was approved by the Ethics Committee of our hospital. was removed by making a 2-cm transverse incision in the location of vestibule ditch to the middle of the red line, slightly left or right.
| Specimen collection and patient grouping
Specimens were fixed using 10% formaldehyde solution, embedded in paraffin, and sectioned with 4 μm thickness.
In the pSS group, specimens of both labial gland and serum were obtained from each pSS patient. However, in the control group, 35 serum specimens and only 23 labial gland specimens were obtained from 35 patients. The expression of CD20 in the labia gland was detected in 71 pSS patients, 66 of which also showed CD3 positive expression, and 5 of which were CD3 negative. Based on the ratio of CD20/CD3 level, the 48 patients were assigned to the high CD20 expression group, because their CD20 was higher than their CD3 level (Figures 1-3 ), while 23 patients were assigned to the low CD20 expression group, because 20 out of the 23 patients showed the same level of CD20 and CD3 and 3 showed their CD20 were lower than their CD3 levels (Figures 1-3 ). In the control group, only a few scattered lymphocytes were seen infiltrating the labial gland, and the expressions of CD3 and CD20 were not detectable.
| Immunohistochemical staining and biochemistry measurements
The expressions of CD20, CD3, IgG, IgA, IgM, C1q, and C3c in each specimen were detected with immunohistochemical universal 2-step method. The monoclonal antibodies of rabbit anti-human CD20, rabbit antihuman CD3 and the polyclonal antibodies of rabbit antihuman IgG, IgA, IgM, complement C3c, and complement C1q
were purchased from Beijing Zhongjin Jinqiao Biotechnology Co.
(Beijing, China); PBS buffer replaced the primary antibody as a negative control; results were stained with 3,3′-diaminobenzidine (DAB).
According to the color intensity and distribution on each slice to determine the expression volume of each target material, it was defined: no color as the negative "-"; partial coloring/light yellow to be the weak positive "+"; diffuse coloring/brown judged as positive "++"; diffuse coloring/dark brown as the strong positive "+++". Serum IgG, IgA, IgM, C3, C4, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were measured by routine biochemistry methods.
Pathological examination was carried out by 3 experienced pathologists independently.
| Statistical analysis
Continuous variables in line with the normal distribution were expressed with mean ± SD and the t test was used to compare 2 independent samples. Continuous variables which do not conform to the normal distribution were expressed with median (IQR) and the Wilcoxon two-sample test was used to compare between the 2 groups. 
| RE SULTS
| The general clinic information of collected 71 pSS patients
We collected general clinic information from all of 71 pSS patients, including disease onset, immune serology, inflammatory markers, and blood parameters (Table 1) .
| Comparison of lymphocyte immunophenotypes from the labial glands between the pSS and control groups
The highest grading with 3 plus signs of IgG, IgA, IgM, and C3c in the labial glands was significantly higher in the pSS group than in the control group, respectively (all P < .05). However, the highest grading with 3 plus signs of C1q levels from the labial glands was significantly lower in the pSS group than in the control group (P < .01) ( Table 2 ).
| Feature comparisons of blood index between the pSS and control groups
The levels of blood IgG, IgA, IgM, ESR, and CRP were higher in the pSS group than in the control group (P < .01), the level of C4 was significantly lower in the pSS group than in the control group (P < .01), and there was a similar level of C3 between 2 groups (Table 3) .
| Comparisons of all measurements between the high and low CD20 expression groups
The mean age of the high CD20 expression group was 45.17 ± 13.30 years, and the lower expression group was 48.48 ± 12.97 years. The course of disease was 4.59 ± 5.48 years in the high CD20 expression group
The interstitia of the labial gland in the control group showed negative immunohistochemical staining (×100): Scattered lymphocyte infiltration was found, but no positive staining for CD3 and Cd20 (brown color) was observed and 3.53 ± 4.61 years in the low CD20 expression group. There was no statistically significant difference on the mean age and the course of disease between 2 groups (P > .05). The other clinical characteristics between low and high CD20 expression patients were also prepared and no statistically significant difference was found (Table 1) .
Unlike the patterns of lymphocyte immune phenotypes from the labial glands between the pSS and control groups, the highest grading with 3 plus signs of IgG and the second highest grading with 2 plus signs of C1q were significantly higher in the high CD20 expression group than in the low CD20 expression group (P < .01) (Figures 4 and 5 ). But no differences were shown on IgA, IgM, and C3c measurements between the 2 groups (Table 4 ).
There were no statistically significant differences in mean age and in the course of disease between 2 groups, respectively (P > .05).
The levels of blood IgG and ESR were higher in high expression group than in low expression group (both P < .05). However, there was no significant difference in serum IgA, IgM, C3, C4, and CRP levels between 2 groups (Table 5 ).
| D ISCUSS I ON
The current study showed that pSS patients had significantly higher serum IgG, IgA, IgM, and CRP and ESR than controls, suggesting an abnormal humoral immune response in the peripheral blood of pSS patients. Moreover, patients with high CD20 expression had significantly higher levels of serum IgG and ESR than those with low CD20 expression, suggesting higher disease activity in the high CD20 expression group.
TA Chistodoulou et al. reported that B cell incidence was positively correlated with infiltration grade and biopsy focus score. 14 CD20 + B lymphocytes were found in the infiltrating lymphocytes of small salivary glands in pSS patients, 15 including autoimmune B cells. 16 Jin et al. should also be delineated. 19 Ectopic germinal center was present in the exocrine glands of 25% pSS patients. 20 A study showed that only 8 out of 54 healthy persons had focal lymphocytic infiltration, salivary gland inflammation, and FS ≥ 1, but they did not have xerophthalmia and xerostomia. 21 Therefore, the level of lymphocyte infiltration in pSS exocrine glands cannot directly reflect the decline of glandular TA B L E 3 Levels of blood immunoglobulin, complement, ESR, and CRP in the pSS and control groups function. We also found no significant difference in extraglandular manifestations of pSS patients in the high and low CD20 expression groups in terms of xerophthalmia and leukocyte reduction.
However, we observed that pSS patients had significantly higher levels of IgG, IgM, and IgA in the labial gland than in the control patients; noticeably, pSS patients with high CD20 expression had appreciably higher IgG levels than those with low CD20 expression. The result indicated that not only lymphocyte infiltration but also immunoglobulin deposition was present in the exocrine glands of pSS patients, which may indicate that IgG predominant pSS is severe.
C3 has been shown to play a role in the occurrence and development of Sjogren's syndrome, especially in early SS. We found that the level of serum C4 was lower in the pSS group than the control group. Furthermore, the C3 level in the labial gland was higher in the pSS group than the control group. Clq is the initiating factor of the classical complement activation pathway. We found that C1q level was lower in the pSS group than the control group, suggesting that complement activation in pSS patients may proceed via the alternative activation pathway. Notably, patients with high CD20 expression had higher C1q levels than patients with low CD20 expression,
suggesting that the classic pathway may also cause tissue injuries when the infiltrating lymphocytes are predominantly CD20 positive cells. In severe pSS, the classic and bypass pathways may be activated simultaneously in the labial glands. Immunoglobulin codeposition may activate the classical complement pathway and contribute to immune damage in labial gland.
A study of 921 pSS patients using the ESSDAI 5 showed that cytopenias, hypocomplementaemia, and cryoglobulinaemia at diagnosis strongly correlated with higher cumulative ESSDAI scores in the clinical domains. The data from our current research not only match the ESSDAI but also provide more detailed information on hypocomplementaemia and cryoglobulinaemia to complement these diagnostic criteria. This result is consistent with the study of the EULAR Sjogren's syndrome group, which suggests that CD3 and CD20 staining of lip glands should be performed in clinical studies and the ratio of B/T cells in lymphocytic infiltrate should also be reported. Brito-Zeron et al. thought that the main prognostic factors for an adverse outcome of pSS were vasculitis, severe involvement in parotid scintigraphy, hypocomplementaemia, and/or cryoglobulins at diagnosis. Patients with at least 2 of these factors need a closer follow-up. 22 Therefore, based on the current result, it is necessary to follow up the CD20 expression in infiltrating lymphocytes in the labial gland, as well as changes of immunoglobulins and complements in both the labial gland and peripheral blood of pSS patients.
We also noted that patients with high CD20 expression had significantly lower levels of serum IL-2 and IL-2R than those with low CD20 expression, while IL-6 and IL-6R levels were comparable between the 2 groups. Tishler et al. found that SS patients had significantly higher salivary levels of IL-2R than dry mouth syndrome patients but noted no significant difference in serum levels of IL-2R between the 2 groups. 23 Tomas et al. also showed that SS patients
Immunity index Grading
High CD20 expression, n (%) had significantly higher serum IL-2R levels, but they found no correlation of serum IL-2R levels with clinical activities of SS. 24 Akiyama et al. have recently shown that serum IL-2R levels correlated with ESSDAI scores and the number of affected organs in pSS. 25 The significance of sera IL-2 and IL-2R levels in pSS patients remains to be further defined.
In conclusion, both CD3 + T lymphocytes and CD20 + B lymphocytes were found in the labial gland of pSS patients and CD20 + B lymphocytes may be predominant in patients with a longer disease course. Furthermore, deposits of immunoglobulin and complement were present in the labial glands of pSS patients.
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